ARVINAS, INC. (ARVN) Corporate Subsidiaries
ARVINAS, INC. (ARVN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ARVN
CIK: 1655759
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerJames Holmes
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-8 | 2026-09-28 | — | S-8 | 0001628280-26-063710 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001950047-26-009754 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001950047-26-009237 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001950047-26-009128 | View SEC Doc Filr Page |
| S-8 | 2026-08-31 | — | S-8 | 0001628280-26-059573 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097189 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001950047-26-007606 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001628280-26-052554 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001628280-26-052139 | View SEC Doc Filr Page |
| 144 | 2026-07-09 | — | 144 Filing | 0001950047-26-006977 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045788 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045787 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045786 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045785 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045783 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001628280-26-045781 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-24 | 8-K | 0001628280-26-045520 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-24 | FORM 4 | 0001628280-26-045286 | View SEC Doc Filr Page |
| 144 | 2026-06-23 | — | 144 Filing | 0001628280-26-044980 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-22 | 8-K | 0001628280-26-044627 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | FORM 4 | 0001628280-26-044270 | View SEC Doc Filr Page |
| 144 | 2026-06-17 | — | 144 Filing | 0001628280-26-043732 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-11 | 8-K | 0001628280-26-043559 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-06-02 | 8-K | 0001628280-26-039818 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-21 | FORM 4 | 0001628280-26-037728 | View SEC Doc Filr Page |